FDA Approves Repatha® (evolocumab) In Pediatric Patients Age 10 And Older With Heterozygous Familial Hypercholesterolemia
Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Repatha® (evolocumab) as an…
Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Repatha® (evolocumab) as an…
THOUSAND OAKS, Calif., Sept. 24, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration…
year,cybersecurity sector roundup,palo alto,revenue,cost of safety,company,investments limited,ended 31 july,financial conduct…
Gold Line Resources Ltd. (TSXV: GLDL) (Frankfurt: 4UZ) (WKN: A2QGWC) (OTCQB: TLLZF) (“Gold Line” or the “Company”) is pleased…
Viewing insider transactions for Castile Resources Limited’s ( ASX:CST ) over the last year, we see that insiders were…
The average equity fund was only down 0.07% for the fund flows week. Equity funds (including ETFs) witnessed net outflows of…
NEW YORK, NY / ACCESSWIRE / September 24, 2021 / Labaton Sucharow, a nationally ranked and award-winning shareholder rights firm,…
How far off is Cochlear Limited ( ASX:COH ) from its intrinsic value? Using the most recent financial data, we’ll take…
NEW YORK, NY / ACCESSWIRE / September 24, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on…
SAN FRANCISCO, CA / ACCESSWIRE / September 24, 2021 / Hagens Berman urges Zymergen Inc. (NASDAQ:ZY) investors with significant…